Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Brain disconnectome mapping derived from white matter lesions and serum neurofilament light levels in multiple sclerosis: A longitudinal multicenter study.
Rise HH, Brune S, Chien C, Berge T, Bos SD, Andorrà M, Valdeolivas IP, Beyer MK, Sowa P, Scheel M, Brandt AU, Asseyer S, Blennow K, Pedersen ML, Zetterberg H, de Schotten MT, Cellerino M, Uccelli A, Paul F, Villoslada P, Harbo HF, Westlye LT, Høgestøl EA. Rise HH, et al. Among authors: cellerino m. Neuroimage Clin. 2022;35:103099. doi: 10.1016/j.nicl.2022.103099. Epub 2022 Jun 25. Neuroimage Clin. 2022. PMID: 35772194 Free PMC article.
Different MRI patterns in MS worsening after stopping fingolimod.
Lapucci C, Baroncini D, Cellerino M, Boffa G, Callegari I, Pardini M, Novi G, Sormani MP, Mancardi GL, Ghezzi A, Zaffaroni M, Uccelli A, Inglese M, Roccatagliata L. Lapucci C, et al. Among authors: cellerino m. Neurol Neuroimmunol Neuroinflamm. 2019 Apr 16;6(4):e566. doi: 10.1212/NXI.0000000000000566. eCollection 2019 Jul. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 31086807 Free PMC article.
Impact of treatment on cellular immunophenotype in MS: A cross-sectional study.
Cellerino M, Ivaldi F, Pardini M, Rotta G, Vila G, Bäcker-Koduah P, Berge T, Laroni A, Lapucci C, Novi G, Boffa G, Sbragia E, Palmeri S, Asseyer S, Høgestøl E, Campi C, Piana M, Inglese M, Paul F, Harbo HF, Villoslada P, Kerlero de Rosbo N, Uccelli A. Cellerino M, et al. Neurol Neuroimmunol Neuroinflamm. 2020 Mar 5;7(3):e693. doi: 10.1212/NXI.0000000000000693. Print 2020 May. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32139439 Free PMC article.
Assessing upper limb function in multiple sclerosis using an engineered glove.
Carmisciano L, Signori A, Pardini M, Novi G, Lapucci C, Nesi L, Gallo E, Laroni A, Cellerino M, Meli R, Sbragia E, Filippi L, Uccelli A, Inglese M, Sormani MP. Carmisciano L, et al. Among authors: cellerino m. Eur J Neurol. 2020 Dec;27(12):2561-2567. doi: 10.1111/ene.14482. Epub 2020 Sep 9. Eur J Neurol. 2020. PMID: 32805743
Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis.
Cellerino M, Boffa G, Lapucci C, Tazza F, Sbragia E, Mancuso E, Bruschi N, Minguzzi S, Ivaldi F, Poirè I, Laroni A, Mancardi G, Capello E, Uccelli A, Novi G, Inglese M. Cellerino M, et al. Neurotherapeutics. 2021 Oct;18(4):2579-2588. doi: 10.1007/s13311-021-01104-8. Epub 2021 Sep 22. Neurotherapeutics. 2021. PMID: 34553320 Free PMC article.
56 results